Cargando…
Updated Management of Colorectal Cancer Liver Metastases: Scientific Advances Driving Modern Therapeutic Innovations
Colorectal cancer is the second leading cause of cancer-related deaths in the United States and accounts for an estimated 1 million deaths annually worldwide. The liver is the most common site of metastatic spread from colorectal cancer, significantly driving both morbidity and mortality. Although r...
Autores principales: | Patel, Ranish K., Rahman, Shahrose, Schwantes, Issac R., Bartlett, Alexandra, Eil, Robert, Farsad, Khashayar, Fowler, Kathryn, Goodyear, Shaun M., Hansen, Lissi, Kardosh, Adel, Nabavizadeh, Nima, Rocha, Flavio G., Tsikitis, V. Liana, Wong, Melissa H., Mayo, Skye C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10598050/ https://www.ncbi.nlm.nih.gov/pubmed/37678799 http://dx.doi.org/10.1016/j.jcmgh.2023.08.012 |
Ejemplares similares
-
Combined locoregional and systemic therapy for advanced hepatocellular carcinoma: finally, the future is obscure
por: Farsad, Khashayar, et al.
Publicado: (2020) -
Gut microbial metabolites and its impact on human health
por: Rahman, Shahrose, et al.
Publicado: (2023) -
The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation
por: IV, Arthur Affleck, et al.
Publicado: (2022) -
Geographic Disparities in Referral Rates and Oncologic Outcomes of Intrahepatic Cholangiocarcinoma: A Population-Based Study
por: Sutton, Thomas L., et al.
Publicado: (2021) -
Phase 2 study of preoperative chemotherapy with nab‐paclitaxel and gemcitabine followed by chemoradiation for borderline resectable or node‐positive pancreatic ductal adenocarcinoma
por: Chen, Emerson Y., et al.
Publicado: (2023)